Andon Health Co., Ltd. (SHE:002432)
China flag China · Delayed Price · Currency is CNY
59.20
-2.20 (-3.58%)
Sep 14, 2026, 3:04 PM CST

Andon Health Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
1,1241,3562,5783,17226,2652,340
Other Revenue
7.549.8513.8558.6650.5157.06
1,1321,3662,5923,23126,3152,397
Revenue Growth
-43.60%-47.32%-19.77%-87.72%997.80%19.36%
Cost of Revenue
433.25523.38784.961,2755,529884.82
Gross Profit
698.35842.211,8071,95620,7861,512
Selling, General & Admin
694.26845.71863.38886.052,004496.55
Research & Development
270.95323.57260.69278.46264.8966.73
Other Operating Expenses
2.69-0.023.441.64.156.25
Operating Expenses
966.381,1661,1301,2032,286592.96
Operating Income
-268.04-324.28677.15752.6618,500919.31
Interest Expense
-127.24-113.52-67.16-12.43-4.75-13.3
Interest & Investment Income
562.11857.48800.45735.36274.162.35
Currency Exchange Gain (Loss)
-106.0710.34-11.9240.1335.26-2.2
Other Non Operating Income (Expenses)
-4.08-4.09-2.26-2.8-1.98-3.86
EBT Excluding Unusual Items
56.69425.921,3961,51318,803962.29
Impairment of Goodwill
----89.5-125.26-
Gain (Loss) on Sale of Investments
5,0272,114735.6309.29-326.430.49
Gain (Loss) on Sale of Assets
-0.97-0.010.67-0.5-6.430.01
Asset Writedown
-5.6-5.32-25.45-153.14-46.95-1.88
Other Unusual Items
-8.71-6.87-0.21.28-39.858.72
Pretax Income
5,0692,5272,1071,58018,258999.63
Income Tax Expense
645.26257.75306.83231.111,77465.23
Earnings From Continuing Operations
4,4242,2701,8001,34916,484934.4
Minority Interest in Earnings
-6.74-2.76-131.31-97.62-453.93-25.76
Net Income
4,4172,2671,6691,25216,030908.64
Net Income to Common
4,4172,2671,6691,25216,030908.64
Net Income Growth
122.27%35.84%33.33%-92.19%1664.19%274.96%
Shares Outstanding (Basic)
424433438445456455
Shares Outstanding (Diluted)
425435441452467455
Shares Change
-3.31%-1.38%-2.49%-3.23%2.82%5.02%
EPS (Basic)
10.415.233.812.8135.142.00
EPS (Diluted)
10.395.213.782.7734.302.00
EPS Growth
129.87%37.73%36.73%-91.93%1615.80%257.03%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
-587.4-431.13912.831,55718,010222.67
Free Cash Flow Per Share
-1.38-0.992.073.4438.530.49
Dividend Per Share
1.6501.6500.2000.3002.5000.700
Dividend Growth
725.00%725.00%-33.33%-88.00%257.14%1066.67%
Gross Margin
61.71%61.67%69.72%60.54%78.99%63.09%
Operating Margin
-23.69%-23.75%26.12%23.29%70.30%38.35%
Profit Margin
390.32%165.99%64.38%38.74%60.92%37.91%
Free Cash Flow Margin
-51.91%-31.57%35.22%48.20%68.44%9.29%
EBITDA
-247.92-297.33730.86829.0818,574985.28
EBITDA Margin
-21.91%-21.77%28.19%25.66%70.58%41.10%
D&A For EBITDA
20.1226.9653.7176.4274.1865.97
EBIT
-268.04-324.28677.15752.6618,500919.31
EBIT Margin
-23.69%-23.75%26.12%23.29%70.30%38.35%
Effective Tax Rate
12.73%10.20%14.56%14.62%9.71%6.53%
Revenue as Reported
1,1321,3662,5923,23126,3152,397
Advertising Expenses
-85.82108.8282.7770.3851.22